about
HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitroMaximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cellsCell Fusion in the War on Cancer: A Perspective on the Inception of MalignancyCRISPR/Cas9 and cancer targets: future possibilities and present challengesTumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11Cell fusion induced by ERVWE1 or measles virus causes cellular senescenceThe genetic analysis of cancerViruses and human cancers: a long road of discovery of molecular paradigms.Recessive mechanisms of malignancy.Drosophila as a model system for molecular analysis of tumorigenesis.The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell ProliferationA note from history: Landmarks in history of cancer, part 7.Positive selection of candidate tumor-suppressor genes by subtractive hybridization.Chemicals, cancer and cancer biologyTargeting tumor suppressor networks for cancer therapeutics.Effect of loss of thymidine kinase activity on the tumorigenicity of clones of SV40-transformed hamster cells.A new functional classification of tumor-suppressing genes and its therapeutic implications.Tissue preference and differentiation of malignant rat x mouse hybrid cells in chimaeric mouse fetuses.Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control.Nuclear reprogramming to a pluripotent state by three approaches.Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22.Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumorsSimilar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.Prostatic carcinogenesis evoked by cellular interactionA general theory of carcinogenesis.Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer.In vitro derived mouse A9 cell clones differing in malignancy: analysis by somatic cell hybridization with YACIR lymphoma cell clonesTumorigenicity of simian virus 40-transformed human cells and mouse--human hybrids in nude miceOncogenes and tumor-suppressor genes.Enhanced oncogenic behavior of human and mouse cells after cellular hybridization with Burkitt tumor cellsSomatic cell hybrids between mouse peritoneal macrophages and simian-virus-40-transformed human cells: II. Presence of human chromosome 7 carrying simin virus 40 genome in cells of tumors induced by hybrid cells.Assignment of gene(s) for cell transformation to human chromosome 7 carrying the simian virus 40 genomeTumor-associated transplantation antigens in immune rejection of mouse malignant cell hybrids.Using heterokaryons to understand pluripotency and reprogrammingCoincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3.Sir John Gurdon: father of nuclear reprogramming.Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II.Cancer risks from germline p53 mutations.
P2860
Q24336517-8DA15635-6EE8-441B-B182-1532D2375474Q24528249-CAD6A73B-13B4-4937-8C98-81E5676787BCQ26740111-1AD60138-C9CB-4F9F-9717-803AB3B4B116Q26769907-23812275-53B8-4765-B146-7F84B6A3020BQ28267975-A0E8F82C-28C8-4BF5-9E31-0A8CDF61614BQ28301290-FCC98FA2-ABD4-498F-9E85-172CF9C963D3Q29030042-902E8368-3482-4362-AA0D-0402BED06B6DQ30384388-926E83BC-F835-4A90-8039-EE0A38783F60Q30486899-67829F4C-C724-4ED4-B5B4-6E9192CB8776Q30498507-FD22597E-204D-4BB0-9ADE-577C5A8B3815Q30659086-278CD113-0F6C-41B8-BB4E-562A53C6142EQ30931923-18C92982-12C7-48A8-84D5-E9A0EC87A7C4Q33336307-60A9C9E6-3BFA-4168-A063-E2B0292FC7E7Q33580718-91158CD1-7010-4EB4-B6BC-2B708588C7A8Q33657519-37513D57-440F-4168-8D89-DAB0F106C86EQ33707574-D2E5F5B6-51F8-4553-A447-1125CBEAD464Q33843457-A2FBB919-88D4-4F96-BF8C-9890F3CA3A0BQ33928317-8F985322-03AF-4C9D-B8DB-5DBB07B9FDC2Q33968827-E6CAAFB7-B3B4-49ED-952C-124D7BFCEC77Q33980410-A163F057-9902-4D9A-A5C8-03FABD5846EFQ34084574-4B162296-CDDB-46A3-AEDD-ED80BF506469Q34508726-B25F7674-6C14-407D-9805-086E06D8D026Q34538564-D7F4BB00-C05C-4F7F-9F5D-DE3E5C39A28EQ34559345-D101D6B7-42AD-4FC6-AE7B-BD0BEF6AC147Q34647968-711414BB-2A05-4D91-BF9F-ED285667B28AQ34660491-7E2431D4-F841-4C48-92D8-C464567C84CDQ34744320-420150A6-D2A7-48C7-9C6D-A401EF88A9A4Q34935982-3D5615A9-E061-4090-8107-BEEAC201B90CQ35005692-99C36BC5-2B54-4E72-A69B-43CDBF52140BQ35012423-8EF63E1B-BBA0-4E91-9617-4BF96F6325C4Q35034093-B7A38F5C-AE09-454E-82F1-4941EE10A322Q35065184-FA9E4025-6575-42B9-A0A1-368C375823A7Q35075886-7201AF3F-B96E-48AA-94BE-1D11C2261C1AQ35077597-001EFDB6-FD30-401D-B42F-51ACB9EC703AQ35081054-12DD4BDE-2ACF-47C0-93D7-1A314C78615DQ35088507-22CC8771-2BE8-4A14-938D-9E57C24B52B7Q35143751-104F5A0D-3D8D-476C-9FDF-73BF130E44E8Q35150779-079E0576-D105-4D05-9E5E-0F1558C64C21Q35197594-8C30858D-3E8D-48F0-9FCF-89905B9E7BA4Q35513831-F9AD3156-80A5-4683-8D10-A146116F636D
P2860
description
1969 nî lūn-bûn
@nan
1969 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1969 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1969年の論文
@ja
1969年論文
@yue
1969年論文
@zh-hant
1969年論文
@zh-hk
1969年論文
@zh-mo
1969年論文
@zh-tw
1969年论文
@wuu
name
Suppression of malignancy by cell fusion.
@ast
Suppression of malignancy by cell fusion.
@en
Suppression of malignancy by cell fusion.
@nl
type
label
Suppression of malignancy by cell fusion.
@ast
Suppression of malignancy by cell fusion.
@en
Suppression of malignancy by cell fusion.
@nl
prefLabel
Suppression of malignancy by cell fusion.
@ast
Suppression of malignancy by cell fusion.
@en
Suppression of malignancy by cell fusion.
@nl
P2093
P356
P1433
P1476
Suppression of malignancy by cell fusion.
@en
P2093
P2860
P2888
P304
P356
10.1038/223363A0
P407
P50
P577
1969-07-01T00:00:00Z
P5875
P6179
1035583653